Viewing StudyNCT00338585

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 4:54 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00338585
Status: TERMINATED
Last Update Posted: 2008-01-15
First Post: 2006-06-15
Brief Title: Study of Alfimeprases Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery
Sponsor: ARCA Biopharma Inc
Organization: ARCA Biopharma Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Arterial Occlusive Diseases
Keywords:
Name View
arterial flow View
PAO View
acute peripheral arterial occlusion View
thrombolysis View
blood clot View
leg attack View
alfimeprase View
thrombus View
embolism View
thromboembolism View
claudication View
thrombolytic View
thrombosis View
plasminogen activator View